19
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Significant Association Between Genetic Polymorphism of Insulin‐Like Growth Factor‐2 mRNA Binding Protein‐2 and Type 2 Diabetes Mellitus: A Population‐Based Case–Control Study

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Objectives

          To determine the association between IGF2BP2 polymorphisms and type 2 diabetes mellitus.

          Methods

          This study involved 422 individuals, 214 diabetes mellitus cases, and 208 healthy controls. The PCR‐RFLP technique was used to determine the genotype of the IGF2BP2 gene for the SNPs rs4402960 (G>T) and rs1470579 (A>C).

          Results

          The results showed that the C allele of the rs1470579 variant and the T allele of the rs440960 variant were significantly associated with type 2 diabetes mellitus group ( p = 0.0029 and 0.0001) as reported for both alleles, respectively. High frequencies of haplotypes TA and TC were observed in type 2 diabetes patients.

          Conclusion

          The present study showed that IGF2BP2 rs1470579 and rs4402960 polymorphism were significantly associated with the increased risk of T2DM in the Saudi Arabian population and presented a genetic model to screen the high‐risk individuals with further validations.

          Abstract

          This study aimed to determine the association between IGF2BP2 polymorphisms and type 2 diabetes mellitus. The present study showed that IGF2BP2 rs1470579 and rs4402960 polymorphism were significantly associated with the increased risk of T2DM in the Saudi Arabian population and presented a genetic model to screen the high‐risk individuals with further validations.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021

          (2020)
          The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

            Diabetes is an increasingly important condition globally and robust estimates of its prevalence are required for allocating resources. Data sources from 1980 to April 2011 were sought and characterised. The Analytic Hierarchy Process (AHP) was used to select the most appropriate study or studies for each country, and estimates for countries without data were modelled. A logistic regression model was used to generate smoothed age-specific estimates which were applied to UN population estimates for 2011. A total of 565 data sources were reviewed, of which 170 sources from 110 countries were selected. In 2011 there are 366 million people with diabetes, and this is expected to rise to 552 million by 2030. Most people with diabetes live in low- and middle-income countries, and these countries will also see the greatest increase over the next 19 years. This paper builds on previous IDF estimates and shows that the global diabetes epidemic continues to grow. Recent studies show that previous estimates have been very conservative. The new IDF estimates use a simple and transparent approach and are consistent with recent estimates from the Global Burden of Disease study. IDF estimates will be updated annually. Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

              The molecular mechanisms involved in the development of type 2 diabetes are poorly understood. Starting from genome-wide genotype data for 1924 diabetic cases and 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to detect replicated diabetes association signals through analysis of 3757 additional cases and 5346 controls and by integration of our findings with equivalent data from other international consortia. We detected diabetes susceptibility loci in and around the genes CDKAL1, CDKN2A/CDKN2B, and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8. Our findings provide insight into the genetic architecture of type 2 diabetes, emphasizing the contribution of multiple variants of modest effect. The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes.
                Bookmark

                Author and article information

                Contributors
                eelssaig@ut.edu.sa
                Journal
                J Clin Lab Anal
                J Clin Lab Anal
                10.1002/(ISSN)1098-2825
                JCLA
                Journal of Clinical Laboratory Analysis
                John Wiley and Sons Inc. (Hoboken )
                0887-8013
                1098-2825
                03 January 2025
                February 2025
                : 39
                : 3 ( doiID: 10.1002/jcla.v39.3 )
                : e25147
                Affiliations
                [ 1 ] Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences University of Tabuk Tabuk Saudi Arabia
                [ 2 ] Prince Fahad Bin Sultan Chair for Biomedical Research University of Tabuk Tabuk Saudi Arabia
                [ 3 ] Faculty of Medical Laboratory Science Department of Clinical Chemistry Alzaiem Alazhari University Khartoum North Sudan
                [ 4 ] Faculty of Medical Laboratory Science Department of Microbiology and Immunology Alzaiem Alazhari University Khartoum North Sudan
                [ 5 ] Medical Laboratory Specialist‐ Clinical Chemistry Lab ‐King Fahd Specialist Hospital, Tabuk, Kingdom of Saudi Arabia Saudi Arabia
                Author notes
                [*] [* ] Correspondence:

                Elmutuz H. Elssaig ( eelssaig@ 123456ut.edu.sa )

                Author information
                https://orcid.org/0000-0003-3136-1899
                https://orcid.org/0000-0001-5880-793X
                https://orcid.org/0000-0001-9005-0375
                https://orcid.org/0000-0002-9281-1550
                Article
                JCLA25147 JCLA-24-400.R2
                10.1002/jcla.25147
                11821720
                39749895
                d404af76-d32d-4733-9b14-6cf1eb0cdeee
                © 2025 The Author(s). Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 28 November 2024
                : 10 June 2024
                : 22 December 2024
                Page count
                Figures: 6, Tables: 8, Pages: 9, Words: 5300
                Funding
                Funded by: Deanship of Scientific Research (DSR), University of Tabuk, Kingdom of Saudi Arabia
                Award ID: S‐0115‐1439
                Categories
                Research Article
                Research Article
                Custom metadata
                2.0
                February 2025
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.3 mode:remove_FC converted:13.02.2025

                Clinical chemistry
                bmi,genetic variants,genomic markers,igf2bp2,snps,t2dm
                Clinical chemistry
                bmi, genetic variants, genomic markers, igf2bp2, snps, t2dm

                Comments

                Comment on this article